Developmental expression of metabotropic P2Y1 and P2Y2 receptors in freshly isolated astrocytes from rat hippocampus

被引:61
作者
Zhu, YZ
Kimelberg, HK
机构
[1] Albany Med Coll, Div Neurosurg, Albany, NY 12208 USA
[2] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA
关键词
astrocytes; Ca2+ imaging; rat hippocampus; P2Y(1); P2Y(2); single cell RT-PCR;
D O I
10.1046/j.1471-4159.2001.00241.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There are at least three subtypes of cloned metabotropic P2 receptors linked to intracellular Ca2+ rises in rat brain cells, namely, P2Y(1), P2Y(2) and P2Y(4). In this study we explore the subtypes of the metabotropic P2 receptors seen in freshly isolated astrocytes (FIAs) from P8-P25 rats. We found by single cell RT-PCR that in process-bearing FIAs from hippocampi of P8-P12 rats, 31% of the glial fibrillary acidic protein (GFAP) mRNA (+) cells expressed P2Y(1) mRNA while only 5% of the cells tested expressed P2Y(2) mRNA. The expression of P2Y(1) receptor mRNA was not changed in FIAs from the hippocampi of P18-P25 rats, but 38% of the GFAP mRNA (+) cells in the P18-P25 age group then showed P2Y(2) mRNA. We also studied whether the mRNA was expressing functional receptor protein by measuring Ca2+ responses to specific agonists for P2Y(1) and P2Y(2). We found that similar proportions of GFAP mRNA (+) FIAs responded to ATP or UTP as showed mRNAs for P2Y(1) and P2Y(2), respectively. Total tissue RNA from P9 and P24 rat hippocampus showed a 2.8-fold increase in P2Y(2) mRNA levels from P9 to P24 with a decrease in P2Y(1) mRNA. Thus, this study shows a marked up-regulation of mRNA for P2Y(2) from 9 to 24 days in rat hippocampus, and some of this increase is likely due to the protoplasmic astrocytes which is being translated into functional receptor protein in these cells.
引用
收藏
页码:530 / 541
页数:12
相关论文
共 59 条
[1]   Pharmacological characterisation of metabotropic glutamatergic and purinergic receptors linked to Ca2+ signalling in hippocampal astrocytes [J].
Bernstein, M ;
Behnisch, T ;
Balschun, D ;
Reymann, KG ;
Reiser, G .
NEUROPHARMACOLOGY, 1998, 37 (02) :169-178
[2]   A P2X PURINOCEPTOR CDNA CONFERRING A NOVEL PHARMACOLOGICAL PROFILE [J].
BO, XN ;
ZHANG, Y ;
NASSAR, M ;
BURNSTOCK, G ;
SCHOEPFER, R .
FEBS LETTERS, 1995, 375 (1-2) :129-133
[3]   Characterization of the signalling pathways involved in ATP and basic fibroblast growth factor-induced astrogliosis [J].
Bolego, C ;
Ceruti, S ;
Brambilla, R ;
Puglisi, L ;
Cattabeni, F ;
Burnstock, G ;
Abbracchio, MP .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (08) :1692-1699
[4]  
Cai ZH, 2000, GLIA, V29, P70, DOI 10.1002/(SICI)1098-1136(20000101)29:1<70::AID-GLIA7>3.0.CO
[5]  
2-V
[6]  
Cai ZH, 1997, GLIA, V21, P380, DOI 10.1002/(SICI)1098-1136(199712)21:4<380::AID-GLIA5>3.0.CO
[7]  
2-7
[8]   MOLECULAR-CLONING AND FUNCTIONAL-ANALYSIS OF A NOVEL P-2 NUCLEOTIDE RECEPTOR [J].
CHANG, KG ;
HANAOKA, K ;
KUMADA, M ;
TAKUWA, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (44) :26152-26158
[9]  
Collo G, 1996, J NEUROSCI, V16, P2495
[10]  
Cotrina ML, 1998, J NEUROSCI, V18, P8794